REVISTA ESPAÑOLA DE
CARDIOLOGÍA
ISSN: 0300-8932 Factor de impacto 2023 7,2
Vol. 65. Núm. 6.
Páginas 559 (Junio 2012)

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Chicago, Illinois, Estados Unidos, 24–27 de marzo de 2012)

Summary of the Clinical Studies Reported in the Annual Scientific Sessions of the American College of Cardiology (Chicago. Illinois. United States. March 24–27. 2012)

Pablo AvanzasaAntoni Bayes-GenisaLeopoldo Pérez de IslaaJuan SanchisaMagda Herasb
https://doi.org/10.1016/j.recesp.2012.04.003
Ver PDF
Read this article in English
Compartir

Opciones

Este artículo solo puede leerse en pdf
Bibliografía
[1]
Bermejo J, Segovia J, Alfonso F..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (New Orleans. Estados Unidos, 8–12 de noviembre de 2008)..
Rev Esp Cardiol. , (2009), 62 pp. 178-187
[2]
Segovia J, Bermejo J, Alfonso F..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Orlando. Estados Unidos, 28–31 de marzo de 2009)..
Rev Esp Cardiol. , (2009), 62 pp. 660-669
Medline
[3]
Heras M, Bermejo J, Segovia J, Alfonso F..
Resumen de los ensayos clínicos presentados en las sesiones científicas del Congreso de la Sociedad Europea de Cardiología (Barcelona España, 29 de agosto-2 de septiembre de 2009)..
Rev Esp Cardiol. , (2009), 62 pp. 1149-1160
Medline
[4]
Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando Estados Unidos, 14–18 de noviembre de 2009)..
Rev Esp Cardiol. , (2010), 63 pp. 190-199
Medline
[5]
Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Atlanta Estados Unidos, 14–16 de marzo de 2010)..
Rev Esp Cardiol. , (2010), 63 pp. 695-707
Medline
[6]
Bayes-Genis A, Avanzas P, Pérez de Isla L, Sanchis J, Heras M..
Resumen de estudios clínicos presentados en el Congreso de 2010 de la European Society of Cardiology (28 de agosto-1 de septiembre de 2010, Estocolmo Suecia)..
Rev Esp Cardiol. , (2010), 63 pp. 1292-1303
Medline
[7]
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Chicago Estados Unidos, 13–17 de noviembre de 2010)..
Rev Esp Cardiol. , (2011), 64 pp. 59.e1-59.e8
[8]
Avanzas P, Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Nueva Orleans, Luisiana Estados Unidos, 2–5 de abril de 2011)..
Rev Esp Cardiol. , (2011), 64 pp. 508.e1-508.e8
[9]
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..
Resumen de estudios clínicos presentados en el Congreso de 2011 de la European Society of Cardiology (27–30 de agosto de 2011, París, Francia)..
Rev Esp Cardiol. , (2011), 64 pp. 1011.e1-1011.e8
[10]
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando, Estados Unidos, 12–16 de noviembre de 2011)..
Rev Esp Cardiol. , (2012), 65 pp. 71.e1-71.e9
[11]
Aversano T, Lemmon CC, Liu L. for the Atlantic CPORT Investigators. Outcomes of PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2012 [Epub ahead of print March 25] [citado 27 Mar 2012]. DOI: 10.1056/NEJMoa1114540. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1114540?query=featured_home..
Aversano T, Lemmon CC, Liu L. for the Atlantic CPORT Investigators. Outcomes of PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2012 [Epub ahead of print March 25] [citado 27 Mar 2012]. DOI: 10.1056/NEJMoa1114540. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1114540?query=featured_home.
[12]
Stone GW, Maehara A, Witzenbichler B, Jacek Godlewski J, Parise H, Dambrink JHE, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction. The INFUSE-AMI randomized trial. JAMA. 2012 March 25 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.421. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.421.full..
Stone GW, Maehara A, Witzenbichler B, Jacek Godlewski J, Parise H, Dambrink JHE, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction. The INFUSE-AMI randomized trial. JAMA. 2012 March 25 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.421. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.421.full.
[13]
Randomized comparison of adding cilostazol versus doubling the dose of clopidogrel after receiving percutaneous coronary intervention: The HOST-ASSURE Randomized Trial. Presented by Kyung Woo Park at the ACC.12/i2 Summit, Chicago, Ill, March 25, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@scon/documents/downloadable/ucm_438682.pdf..
Randomized comparison of adding cilostazol versus doubling the dose of clopidogrel after receiving percutaneous coronary intervention: The HOST-ASSURE Randomized Trial. Presented by Kyung Woo Park at the ACC.12/i2 Summit, Chicago, Ill, March 25, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@scon/documents/downloadable/ucm_438682.pdf.
[14]
Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1200384. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200384?query=featured_home..
Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1200384. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200384?query=featured_home.
[15]
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012 March 24[citado 27 Mar 2012]. DOI: 10.1056/NEJMoa1200933. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200933?query=featured_home - t=abstract..
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012 March 24[citado 27 Mar 2012]. DOI: 10.1056/NEJMoa1200933. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200933?query=featured_home - t=abstract.
[16]
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1200225. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200225?query=featured_home..
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1200225. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200225?query=featured_home.
[17]
Long-term reduction in LDL-C early in life. Presented by Brian Anthony Ference at the ACC.12/i2 Summit, Chicago, Ill, March 26, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438685.pdf..
Long-term reduction in LDL-C early in life. Presented by Brian Anthony Ference at the ACC.12/i2 Summit, Chicago, Ill, March 26, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438685.pdf.
[18]
McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA. A randomized, double-blind, placebo-controlled trial of the safety and efficacy of a monoclonal antibody to PCSK9, SAR236553/REGN727, in patients with primary hypercholesterolemia. Presented by James M. McKenney at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438651.pdf..
McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA. A randomized, double-blind, placebo-controlled trial of the safety and efficacy of a monoclonal antibody to PCSK9, SAR236553/REGN727, in patients with primary hypercholesterolemia. Presented by James M. McKenney at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438651.pdf.
[19]
Berwanger O, Guimarães HP, Laranjeira LN, Cavalcanti AB, Kodama AA, Zazula AD, et al. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil. The BRIDGE-ACS Randomized Trial. JAMA. 2012 March 25 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.413. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.413.full..
Berwanger O, Guimarães HP, Laranjeira LN, Cavalcanti AB, Kodama AA, Zazula AD, et al. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil. The BRIDGE-ACS Randomized Trial. JAMA. 2012 March 25 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.413. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.413.full.
[20]
Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1201163. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1201163?query=featured_home..
Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1201163. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1201163?query=featured_home.
[21]
ROMICAT II- Rule OUT Myocardial Ischemia/Infarction Using Computer Assisted Tomography. Presented by Udo Hoffmann at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@scon/documents/downloadable/ucm_438649.pdf..
ROMICAT II- Rule OUT Myocardial Ischemia/Infarction Using Computer Assisted Tomography. Presented by Udo Hoffmann at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@scon/documents/downloadable/ucm_438649.pdf.
[22]
Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D’Agostino RB, et al. Outof-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes. The IMMEDIATE randomized controlled trial. JAMA. 2012 March 27 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.426. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.426.full..
Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D’Agostino RB, et al. Outof-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes. The IMMEDIATE randomized controlled trial. JAMA. 2012 March 27 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.426. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.426.full.
[23]
Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012 March 26 [citado 26 Mar 2012]. DOI: 10.1056/NEJMoa1200388. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200388?query=featured_home..
Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012 March 26 [citado 26 Mar 2012]. DOI: 10.1056/NEJMoa1200388. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1200388?query=featured_home.
[24]
Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 March 27 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1110717. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1110717?query=featured_home#t=abstract..
Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 March 27 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1110717. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1110717?query=featured_home#t=abstract.
[25]
The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1113572. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1113572?query=featured_home#t=articleBackground..
The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1113572. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1113572?query=featured_home#t=articleBackground.
[26]
Moderate Pulmonary Embolism Treated with Thrombolysis 26 (MOPETT Study). Presented by Mohsen Sharifi at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438752.pdf..
Moderate Pulmonary Embolism Treated with Thrombolysis 26 (MOPETT Study). Presented by Mohsen Sharifi at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438752.pdf.
[27]
Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DXM, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure. The FOCUS-CCTRN Trial. JAMA. 2012 March 24 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.418. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.418.ful..
Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DXM, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure. The FOCUS-CCTRN Trial. JAMA. 2012 March 24 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.418. Disponible en: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.418.ful.
[28]
Pacemaker therapy in patients with neurally-mediated syncope and documented asystole. ISSUE 3 Trial. Presented by Michele Brignole at the ACC.12/i2 Summit, Chicago, Ill, March 26, 2012 [citado 28 Mar 2012]. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438684.pdf..
Pacemaker therapy in patients with neurally-mediated syncope and documented asystole. ISSUE 3 Trial. Presented by Michele Brignole at the ACC.12/i2 Summit, Chicago, Ill, March 26, 2012 [citado 28 Mar 2012]. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438684.pdf.
¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?